Affiliation:
1. From the Department of Medicine, Jagellonian University School of Medicine, Krakow, Poland, and the Department of Biochemistry, University of Vermont, Burlington, Vt (K.B., K.G.M.).
Abstract
Background
Mechanisms by which the Pl
A2
(Leu33Pro) polymorphism of β
3
integrins could lead to an increased risk for coronary events are unclear. This study was designed to examine the effect of this polymorphism on blood coagulation.
Methods and Results
In normal subjects (12 with Pl
A1A1
, 9 with Pl
A1A2
, and 3 with Pl
A2A2
), we evaluated the activation of prothrombin, factor V, and factor XIII and fibrinogen removal by quantitative immunoblotting; thrombin-antithrombin III complex generation using ELISA; and levels of fibrinopeptide A and B by high-performance liquid chromatography in blood collected every 30 seconds at sites of standardized microvascular injury before and after 7 days of aspirin ingestion (75 mg/d). Compared with the Pl
A1A1
subjects, the Pl
A2
carriers exhibited higher maximum rates of thrombin B-chain generation (by 31.6%;
P
=0.005), thrombin-antithrombin III complex generation (by 30.7%;
P
=0.003), fibrinogen consumption (by 31.3%;
P
=0.002), prothrombin consumption (by 26.1%;
P
=0.011), and activation of factor V (by 14.1%;
P
=0.033) and factor XIII (by 27.0%;
P
=0.012). In the Pl
A1A1
homozygotes, aspirin ingestion resulted in reductions in the velocity of thrombin B-chain formation (by 32.1%;
P
=0.007), prothrombin consumption (by 30.4%;
P
=0.018), factor Va generation (by 28.9%;
P
=0.014), fibrinogen removal (by 41.2%;
P
=0.001), and factor XIII activation (by 22.6%;
P
=0.026). In the Pl
A2
carriers, aspirin did not alter the velocity of all these processes. After aspirin ingestion, fibrinopeptide A and B concentrations in the last 30-second interval were significantly reduced, but only in the Pl
A1A1
subjects.
Conclusions
The presence of the Pl
A2
allele is associated with enhanced thrombin formation and an impaired antithrombotic action of aspirin, which might favor coronary thrombosis in the Pl
A2
carriers.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Cited by
136 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献